The TCR-based therapy market is projected to grow at an annualized rate of 51%, claims Roots Analysis Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various disease indications For additional details, please visit https://www.rootsanalysis.com/....reports/tcr-based-th or email sales@rootsanalysis.com